• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维斯科特-奥尔德里奇综合征和X连锁先天性血小板减少症由同一基因的突变引起。

The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.

作者信息

Zhu Q, Zhang M, Blaese R M, Derry J M, Junker A, Francke U, Chen S H, Ochs H D

机构信息

Department of Pediatrics, University of Washington School of Medicine, Seattle 98195, USA.

出版信息

Blood. 1995 Nov 15;86(10):3797-804.

PMID:7579347
Abstract

The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, small platelets, eczema, recurrent infections, and immunodeficiency. Besides the classic WAS phenotype, there is a group of patients with congenital X-linked thrombocytopenia (XLT) who have small platelets but only transient eczema, if any, and minimal immune deficiency. Because the gene responsible for WAS has been sequenced, it was possible to correlate the WAS phenotypes with WAS gene mutations. Using a fingerprinting screening technique, we determined the approximate location of the mutation in 13 unrelated WAS patients with mild to severe clinical symptoms. Direct sequence analysis of cDNA and genomic DNA obtained from patient-derived cell lines showed 12 unique mutations distributed throughout the WAS gene, including insertions, deletions, and point mutations resulting in amino acid substitutions, termination, exon skipping, or splicing defects. Of 4 unrelated patients with the XLT phenotype, 3 had missense mutations affecting exon 2 and 1 had a splice-site mutation affecting exon 9. Patients with classic WAS had more complex mutations, resulting in termination codons, frameshift, and early termination. These findings provide direct evidence that XLT and WAS are caused by mutations of the same gene and suggest that severe clinical phenotypes are associated with complex mutations.

摘要

威斯科特-奥尔德里奇综合征(WAS)是一种X连锁隐性疾病,其特征为血小板减少、小血小板、湿疹、反复感染和免疫缺陷。除了典型的WAS表型外,还有一组先天性X连锁血小板减少症(XLT)患者,他们有小血小板,但仅有短暂性湿疹(若有),且免疫缺陷轻微。由于导致WAS的基因已被测序,因此有可能将WAS表型与WAS基因突变相关联。使用指纹筛选技术,我们确定了13名具有轻度至重度临床症状的非亲缘关系WAS患者中突变的大致位置。对从患者来源的细胞系获得的cDNA和基因组DNA进行直接序列分析,发现12种独特的突变分布在整个WAS基因中,包括插入、缺失以及导致氨基酸替换、终止、外显子跳跃或剪接缺陷的点突变。在4名具有XLT表型的非亲缘关系患者中,3名有影响外显子2的错义突变,1名有影响外显子9的剪接位点突变。典型WAS患者有更复杂的突变,导致终止密码子、移码和提前终止。这些发现提供了直接证据,表明XLT和WAS是由同一基因的突变引起的,并表明严重的临床表型与复杂突变相关。

相似文献

1
The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.维斯科特-奥尔德里奇综合征和X连锁先天性血小板减少症由同一基因的突变引起。
Blood. 1995 Nov 15;86(10):3797-804.
2
Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.威斯科特-奥尔德里奇综合征/ X连锁血小板减少症:WASP基因突变、蛋白表达及表型
Blood. 1997 Oct 1;90(7):2680-9.
3
Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.10例日本Wiskott-Aldrich综合征和X连锁血小板减少症患者的WASP基因突变情况
Int J Hematol. 2000 Jan;71(1):79-83.
4
Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.在威斯科特-奥尔德里奇综合征蛋白基因中鉴定出的两种新突变导致威斯科特-奥尔德里奇综合征和血小板减少症。
Int J Mol Med. 2007 May;19(5):777-82.
5
WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.威斯科特-奥尔德里奇综合征和X连锁血小板减少症中的WASP基因突变。
Hum Mol Genet. 1995 Jul;4(7):1127-35. doi: 10.1093/hmg/4.7.1127.
6
X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene.X连锁血小板减少症和威斯科特-奥尔德里奇综合征是由WASP基因突变引起的等位基因疾病。
Nat Genet. 1995 Apr;9(4):414-7. doi: 10.1038/ng0495-414.
7
Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.中国的威斯科特-奥尔德里奇综合征/ X连锁血小板减少症:临床特征及基因型-表型相关性
Pediatr Blood Cancer. 2015 Sep;62(9):1601-8. doi: 10.1002/pbc.25559. Epub 2015 Apr 30.
8
Wiskott-Aldrich syndrome protein and platelets.威斯科特-奥尔德里奇综合征蛋白与血小板
Immunol Rev. 2000 Dec;178:111-7. doi: 10.1034/j.1600-065x.2000.17808.x.
9
[Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].[3例威斯科特-奥尔德里奇综合征男孩中两个新的WASP基因突变的鉴定]
Zhonghua Er Ke Za Zhi. 2003 Aug;41(8):590-3.
10
Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.在10个患有维斯科特-奥尔德里奇综合征和X连锁血小板减少症的澳大利亚家庭中鉴定WASP基因突变。
Pathology. 2004 Jun;36(3):262-4. doi: 10.1080/00313020410001692521.

引用本文的文献

1
New insights into Wiskott-Aldrich syndrome: ten novel mutations and their clinical impact in a Brazilian cohort.威斯科特-奥尔德里奇综合征的新见解:巴西队列中的十个新突变及其临床影响
Front Immunol. 2025 Jul 31;16:1585594. doi: 10.3389/fimmu.2025.1585594. eCollection 2025.
2
Screening for Wiskott-Aldrich Syndrome in Chronic Idiopathic Thrombocytopenic Purpura.慢性特发性血小板减少性紫癜患者中威斯科特-奥尔德里奇综合征的筛查
Indian J Pediatr. 2025 Aug 12. doi: 10.1007/s12098-025-05712-6.
3
Wiskott-Aldrich syndrome: A new synonym mutation in the WAS gene.
威斯科特-奥尔德里奇综合征:WAS基因中的一种新的同义突变。
Intractable Rare Dis Res. 2024 Feb;13(1):69-72. doi: 10.5582/irdr.2023.01102.
4
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.Wiskott-Aldrich 综合征造血干细胞基因治疗的结果。
Blood. 2023 Oct 12;142(15):1281-1296. doi: 10.1182/blood.2022019117.
5
Not too little, not too much: the impact of mutation types in Wiskott-Aldrich syndrome and RAC2 patients.不多不少刚刚好:突变类型对 Wiskott-Aldrich 综合征和 RAC2 患者的影响。
Clin Exp Immunol. 2023 Apr 25;212(2):137-146. doi: 10.1093/cei/uxad001.
6
Wiskott-Aldrich syndrome protein forms nuclear condensates and regulates alternative splicing.Wiskott-Aldrich 综合征蛋白形成核凝聚物并调节选择性剪接。
Nat Commun. 2022 Jun 25;13(1):3646. doi: 10.1038/s41467-022-31220-8.
7
Wiskott-Aldrich syndrome: Oral findings and microbiota in children and review of the literature.威斯科特-奥尔德里奇综合征:儿童的口腔表现和微生物群及文献复习。
Clin Exp Dent Res. 2022 Feb;8(1):28-36. doi: 10.1002/cre2.503.
8
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.慢病毒造血干细胞/祖细胞基因治疗治疗威特综合征的长期安全性和有效性。
Nat Med. 2022 Jan;28(1):71-80. doi: 10.1038/s41591-021-01641-x. Epub 2022 Jan 24.
9
Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of Life.威斯科特-奥尔德里奇综合征的造血干细胞治疗:改善治疗效果和生活质量。
J Blood Med. 2021 Jun 11;12:435-447. doi: 10.2147/JBM.S232650. eCollection 2021.
10
Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding.与血小板特征相关的克隆性造血突变与血栓形成或出血风险。
Haematologica. 2020 Aug;105(8):2020-2031. doi: 10.3324/haematol.2019.235994. Epub 2020 Jun 18.